Original articleStudy on the binding of chiral drug Duloxetine hydrochloride (cas 136434-34-9) to human serum albumin☆
-
Add time:09/05/2019 Source:sciencedirect.com
Duloxetine holds a special promise as an antidepressant, and its effect depends on its binding to human serum albumin (HSA). For this reason, the binding mechanism of duloxetine with HSA was investigated. The specific binding site in HSA was identified and binding constants were determined. Duloxetine could compete with dansyl-L-proline (DLP), a site II marker for binding to site II. Binding constants between duloxetine and HSA were 1.75 × 103 L mol−1 and 3.74 × 103 L mol−1 at pH 7.4 and pH 8.5, respectively. The interaction process of enantiomers and HSA was susceptible to pH change. It was concluded that specific binding position of duloxetine was located in site II, and the B conformation of HSA possibly excelled the N conformation in identifying and binding to enantiomers.
We also recommend Trading Suppliers and Manufacturers of Duloxetine hydrochloride (cas 136434-34-9). Pls Click Website Link as below: cas 136434-34-9 suppliers
Prev:Study on fluorescence characteristics of Duloxetine hydrochloride (cas 136434-34-9)
Next:Original articleCase Report: Fulminant Hepatic Failure Involving Duloxetine hydrochloride (cas 136434-34-9)) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Original ArticleA rapid LC-MS/MS method for simultaneous determination of quetiapine and duloxetine in rat plasma and its application to pharmacokinetic interaction study09/08/2019
- Artifactual formylation of the secondary amine of Duloxetine hydrochloride (cas 136434-34-9) by acetonitrile in the presence of titanium dioxide: Implications for HPLC method development09/07/2019
- Original articleCase Report: Fulminant Hepatic Failure Involving Duloxetine hydrochloride (cas 136434-34-9)09/06/2019
- Study on fluorescence characteristics of Duloxetine hydrochloride (cas 136434-34-9)09/04/2019
- Original Research PaperPreparation and evaluation of Duloxetine hydrochloride (cas 136434-34-9) enteric-coated pellets with different enteric polymers09/03/2019
- Development and validation of an analytical method for the stability of Duloxetine hydrochloride (cas 136434-34-9)09/02/2019
- Optimization and in vivo evaluation of Duloxetine hydrochloride (cas 136434-34-9) buccoadhesive lyophilized tablets09/01/2019
-
Health and Chemical more >